Lucid Diagnostics (LUCD) Preferred Shares (2023 - 2026)

Lucid Diagnostics' Preferred Shares history runs 4 years deep, the most recent figure standing at $10.1 million for Q1 2026.

• Quarterly Preferred Shares fell 81.38% year-over-year to $10.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.1 million (down 81.38% YoY) and the FY2025 annual result came in at $54.3 million, changed 0.27% from the prior year.
• Preferred Shares was $10.1 million for Q1 2026 at Lucid Diagnostics, down from $54.3 million in the prior quarter.
• Across five years, Preferred Shares topped out at $55.9 million in Q2 2024 and bottomed at $10.1 million in Q1 2026.
• A 4-year average of $38.3 million and a median of $54.3 million in 2025 frame the typical range for Preferred Shares.
• Annual changes were most pronounced in 2024 — Preferred Shares soared 310.41% — and 2026, when it tumbled 81.38%.
• Lucid Diagnostics' Preferred Shares stood at $18.6 million in 2023, then soared by 192.18% to $54.4 million in 2024, then dropped by 0.27% to $54.3 million in 2025, then slumped by 81.33% to $10.1 million in 2026.
• Business Quant data shows LUCD's Preferred Shares at $10.1 million in Q1 2026, $54.3 million in Q4 2025, and $54.3 million in Q3 2025.